Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
NCT ID: NCT01656603
Last Updated: 2024-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
9999 participants
INTERVENTIONAL
2012-02-29
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life Improvements With Cord Blood Plasma
NCT03229785
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
NCT01883076
Allogeneic Cord Blood for Neurological Diseases in Adults
NCT05515419
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI
NCT05018832
Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
NCT00696046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Definitions of Infusion-related adverse reactions:
Mild - Moderate: reactions during or after the infusion of the cord blood (CB) product that require some medical intervention but do not affect the overall patient status or outcome.
Severe: serious, life-threatening or fatal infusion reactions, requiring major medical intervention. These include: anaphylactic shock, acute cardiac, pulmonary or renal failure, seizures, patient transfer to the Intensive Care Unit, or death within 48 hours of the CB infusion. Adverse Reactions will also be classified by grade, according to the Common Terminology Criteria for Adverse Events v4.0 (CTCAE).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
unlicensed CBU
The Principal Investigators will be the transplant physicians at participating US transplant centers
unlicensed CBU
infusion of unlicensed cord blood units
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
unlicensed CBU
infusion of unlicensed cord blood units
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients: Patients of any age and either gender
3. Cord blood product manufactured by the NCBP (at least one, if the graft contains more than one units)
Exclusion Criteria
2. Patients who are receiving unlicensed cord blood products from other banks (only)
3. Patients who are transplanted at non-US transplant centers
4. Patients who are receiving cord blood products that will be "manipulated" post-thaw (e.g., ex vivo expansion, incubation in vitro, etc.)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Blood Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Shi, MD
Role: PRINCIPAL_INVESTIGATOR
NY Blood Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's of Alabama
Birmingham, Alabama, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Mayo Clinic Arizona
Phoenix, Arizona, United States
University of Arizona Medical Center
Tucson, Arizona, United States
City of Hope
Duarte, California, United States
UCSD Moores Cancer Center
La Jolla, California, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
UCLA Healthcare
Los Angeles, California, United States
Rady Children's Hospital
San Diego, California, United States
Stanford Health Care
Stanford, California, United States
The Children's Hospital of Colorado
Aurora, Colorado, United States
University of Colorado Hospital
Aurora, Colorado, United States
Presbyterian / St. Luke's Medical Center
Denver, Colorado, United States
Alfred I. DuPont Hospital for Children
Wilmington, Delaware, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Nemour's Children's Clinic and Hospital
Jacksonville, Florida, United States
University of Miami Health System Sylvester Comprehensive Cancer Center
Miami, Florida, United States
University of Miami/Jackson Memorial Hospital
Miami, Florida, United States
Florida Hospital, Florida Center for Cellular Therapy
Orlando, Florida, United States
All Children's Hospital, John Hopkins Medicine
St. Petersburg, Florida, United States
Northside Hosptal
Atlanta, Georgia, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Loyola University Medical Center
Maywood, Illinois, United States
Midwestern Regional Medical Center
Zion, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
James Graham Brown Cancer Center
Louisville, Kentucky, United States
National Institutes of Health
Bethesda, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Dana Farber Cancer Instistute
Boston, Massachusetts, United States
Children's Hospital of Michigan
Detroit, Michigan, United States
Henry Ford Health System
Detroit, Michigan, United States
Helen DeVos Children's Hospital
Grand Rapids, Michigan, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Barnes-Jewish Hospital at University of Washington / Sireman Cancer Center
St Louis, Missouri, United States
St. Louis University Hospital
St Louis, Missouri, United States
The Nebraska Medical Center
Omaha, Nebraska, United States
Northwell Health - North Shore University Hospital
Lake Success, New York, United States
Cohen Children's Medical Center of NY
New Hyde Park, New York, United States
New York Presbyterian Hospital WCMC
New York, New York, United States
Mount Sinai Hospital
New York, New York, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Akron Children's Hospital
Akron, Ohio, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Seidman Cancer Center
Cleveland, Ohio, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Arthur G. James Cancer Hospital
Columbus, Ohio, United States
Stephenson Oklahoma Cancer Center
Oklahoma City, Oklahoma, United States
Southwestern Regional Medical Center
Tulsa, Oklahoma, United States
Doernbecher Children's Hospital / Oregon Health & Science University
Portland, Oregon, United States
Penn State Health / Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Abramson Cancer Center of the University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Children's Hopsital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
St Jude Children's Research Center
Memphis, Tennessee, United States
Children's Medical Center of Dallas
Dallas, Texas, United States
Cook Children's Medical Center
Fort Worth, Texas, United States
Texas Children's Cancer Center
Houston, Texas, United States
Methodist Hospital / Texas Transplant Institute
San Antonio, Texas, United States
University of Virginia
Charlottesville, Virginia, United States
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, United States
Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
Seattle, Washington, United States
West Virginia University Hospitals Inc
Morgantown, West Virginia, United States
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
MD
Role: primary
Sachit Patel, MD
Role: primary
Robert Greiner, MD
Role: primary
Kelly Ross, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6637-01
Identifier Type: -
Identifier Source: org_study_id
NCT01861093
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.